TPVG

TriplePoint Venture Growth BDC Corp. [TPVG] Stock Forecast

Q: What is TriplePoint Venture Growth BDC Corp. stock symbol ?

TriplePoint Venture Growth BDC Corp. is a US stock, located in Menlo park of Ca and trading under the symbol TPVG

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

TPVG Stock Summary

Earnings have grown 43.25% per last year.

EPS has increased from the previous quarter and is now positive. (Quarter statements)

The Moving Average Convergence Divergence (MACD) for TPVG recently turned positive (within last 10 days).

Earnings are expected to fall -100% next year

TPVG's dividend payments are not well covered by cash flows due to its high cash payout ratio (209.81%).

TPVG has less than 1 year of cash runway

Top 10 Correlated ETFs

TPVG

Top 10 Correlated Stocks

TPVG

In the News

08:53 10 Jun 2023 TPVG

TriplePoint Venture Growth: Why The 14.7% Yield Is Not A Trap

TriplePoint currently pays out a 14.7% dividend yield that was raised by 8% earlier this year. The venture debt-focused BDC has fallen around 25% over the last year to push its forward dividend yield to its highest level since the early 2020 pandemic panic.

07:35 10 Jun 2023 TPVG

Seeking At Least 15% Yields

Fear is causing the market to move irrationally. Dividend yields are rising due to higher interest rates, and great new opportunities arise to unlock long-term income.

10:39 10 Jun 2023 TPVG

TriplePoint Venture Growth (TPVG) Crossed Above the 200-Day Moving Average: What That Means for Investors

From a technical perspective, TriplePoint Venture Growth (TPVG) is looking like an interesting pick, as it just reached a key level of support. TPVG recently overtook the 200-day moving average, and this suggests a long-term bullish trend.

04:15 10 Jun 2023 TPVG

TriplePoint Venture Growth BDC Corp. to Announce 2023 First Quarter Financial Results on Wednesday, May 3, 2023

MENLO PARK, Calif.--(BUSINESS WIRE)--TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) (the “Company”), the leading financing provider to venture growth stage companies backed by a select group of venture capital firms in technology and other high growth industries, today announced it will release its financial results for its first quarter ended March 31, 2023 after market-close on Wednesday, May 3, 2023. James P. Labe, chief executive officer and chairman of the board, Sajal K.

10:37 10 Jun 2023 TPVG

TriplePoint Venture Growth (TPVG) Crossed Above the 50-Day Moving Average: What That Means for Investors

TriplePoint Venture Growth (TPVG) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, TPVG broke through the 50-day moving average, which suggests a short-term bullish trend.

09:54 10 Jun 2023 TPVG

5 Dividend Growth Stocks to Buy Amid Looming Uncertainty

Barings BDC (BBDC), Arbor Realty Trust (ABR), Ares Capital (ARCC), Hercules Capital (HTGC) and TriplePoint Venture Growth BDC (TPVG) can be compelling dividend growth picks amid market volatility.

02:00 10 Jun 2023 TPVG

Bank Crash? My Income Is Still Growing

Silicon Valley Bank is no more. One domino has fallen and investors are scattered in panic. When opportunity knocks, are you prepared with fresh cash in hand?

02:51 10 Jun 2023 TPVG

TriplePoint Venture Growth: This 14.6% Yield Is Deeply Discounted

TriplePoint Venture Growth BDC has suffered 13% price drop since last week. The drop is related to market jitters about SVB's failure last week.

01:58 10 Jun 2023 TPVG

Trinity Capital And TriplePoint Venture: 2 BDCs With Potential

Trinity Capital Inc. and TriplePoint Venture Growth recently released their latest earnings; these two have a lot of similarities with each other currently. Net asset value per share for each fell, but these were expected as they dealt with some pains in their portfolios.

11:00 10 Jun 2023 TPVG

2 Dirt-Cheap Dividends To Buy And Win In 2023

Theory is great in theory, reality often destroys what looks good on paper. We look at two BDCs that were beaten down heavily in 2022 but are set to have a stellar 2023.

TPVG Financial details

Company Rating

Buy

Market Cap

381.94M

Income

-26.83M

Revenue

184.16M

Book val./share

11.71

Cash/share

1.62

Dividend

1.59

Dividend %

13.6%

Employees

Optionable

Shortable

Yes

Earnings

01 Aug 2023

P/E

-15.4

Forward P/E

PEG

1.35

P/S

2.25

P/B

P/C

7.24

P/FCF

-2.2

Quick Ratio

Current Ratio

Debt / Equity

LT Debt / Equity

1.48

EPS (TTM)

-0.82

EPS next Y

EPS next Q

EPS this Y

-124.96%

EPS next Y

EPS next 5Y

EPS last 5Y

NAN%

Revenue last 5Y

22.06%

Revenue Q/Q

-71.97%

EPS Q/Q

-133.85%

SMA20

10%

SMA50

-8.33%

SMA100

-8.33%

Inst Own

16.55%

Inst Trans

-1.22%

ROA

-3%

ROE

-6%

ROC

0.09%

Gross Margin

35%

Oper. Margin

51%

Profit Margin

-15%

Payout

-195%

Shs Outstand

35.4M

Shs Float

34.84M

Target Price

15.75

52W Range

9.41-15.24

52W High

-21.8%

52W Low

+30.33%

RSI

Rel Volume

0.42

Avg Volume

305.04K

Volume

129.6K

Perf Week

8.31%

Perf Month

9.32%

Perf Quarter

9.01%

Perf Half Y

-8.36%

Beta

1.76566

Volatility

0.22%, 0.51%

Prev Close

0.34%

Price

11.73

Change

0.26%

TPVG Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	2.15	1.62	1.37	2.69	3.65
Net income per share	1.78	1.28	1.16	5.73	-1.43
Operating cash flow per share	-0.87	-7.55	1.98	-4.68	-3.09
Free cash flow per share	-0.87	-7.55	1.98	-4.68	-3.09
Cash per share	1.14	0.82	1.25	1.66	30.61
Book value per share	16.33	13.38	13.1	14.04	12.85
Tangible book value per share	16.33	27.54	13.1	14.04	12.85
Share holders equity per share	16.33	13.38	13.1	14.04	12.85
Interest debt per share	6.12	13.92	9.05	15.67	23.52
Market cap	223.11M	353.28M	398.58M	555.61M	340.96M
Enterprise value	338.68M	668.75M	621.47M	971.84M	856.45M
P/E ratio	6.1	11.12	11.29	3.13	-7.28
Price to sales ratio	5.06	8.79	9.49	6.66	2.86
POCF ratio	-12.52	-1.88	6.58	-3.84	-3.38
PFCF ratio	-12.52	-1.88	6.58	-3.84	-3.38
P/B Ratio	0.67	1.06	1	1.28	0.81
PTB ratio	0.67	1.06	1	1.28	0.81
EV to sales	7.68	16.64	14.8	11.66	7.17
Enterprise value over EBITDA	7.86	16.01	12.23	10.8	10.45
EV to operating cash flow	-19	-3.57	10.26	-6.72	-8.49
EV to free cash flow	-19	-3.57	10.26	-6.72	-8.49
Earnings yield	0.16	0.09	0.09	0.32	-0.14
Free cash flow yield	-0.08	-0.53	0.15	-0.26	-0.3
Debt to equity	0.4	0	0.71	1.14	1.42
Debt to assets	0.28	0	0.41	0.53	0.59
Net debt to EBITDA	2.68	7.55	4.39	4.63	6.29
Current ratio	0.5	0	12.38	0	5.72
Interest coverage	5.35	4.17	3.28	-0.62	3.37
Income quality	-0.49	-5.91	1.72	-1.89	5.03
Dividend Yield	0.14	0.1	0.11	0.08	0.15
Payout ratio	0.86	1.06	1.2	0.26	-1.06
Sales general and administrative to revenue	0.11	0.15	0.16	0.07	0.06
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	25.61	19.62	18.45	42.56	20.35
ROIC	0.08	0.06	0.08	-0.03	0.23
Return on tangible assets	0.08	0.05	0.05	0.19	-0.05
Graham Net	-5.33	0.82	-8.01	-14.28	12.42
Working capital	-29.63M	20.29M	35.13M	51.27M	825.77M
Tangible asset value	334.53M	684.15M	400.44M	434.49M	419.94M
Net current asset value	-102.58M	20.29M	-244.86M	-441.91M	406.17M
Invested capital	0.36	1.01	0.65	1.08	1.77
Average receivables	0	0	0	0	0
Average payables	72.45M	10M	1.54M	1.54M	0
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	467.48	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0.78	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0.11	0.1	0.09	0.41	-0.11
Capex per share	0	0	0	0	0

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric	2022-03-31	2022-06-30	2022-09-30	2022-12-31	2023-03-31
Revenue per share	0.26	0.88	0.09	3.4	0.95
Net income per share	0.58	-0.68	0.29	-0.65	0.22
Operating cash flow per share	1.75	-2.49	-2.52	0.18	-0.93
Free cash flow per share	1.75	-2.49	-2.52	0.18	-0.93
Cash per share	1.65	1.39	0.21	28.36	1.62
Book value per share	13.85	13.03	13.42	11.9	11.71
Tangible book value per share	13.85	13.03	13.42	11.9	29.6
Share holders equity per share	13.85	13.03	13.42	11.9	11.71
Interest debt per share	13.56	16.16	15.55	21.27	17.58
Market cap	541.45M	395.41M	362.43M	368M	427.02M
Enterprise value	906.52M	848.84M	868.32M	883.49M	981.93M
P/E ratio	7.48	-4.68	9.37	-3.99	13.9
Price to sales ratio	66.11	14.42	116.31	3.07	12.7
POCF ratio	9.99	-5.11	-4.31	57.43	-12.96
PFCF ratio	9.99	-5.11	-4.31	57.43	-12.96
P/B Ratio	1.26	0.98	0.81	0.88	1.03
PTB ratio	1.26	0.98	0.81	0.88	1.03
EV to sales	110.69	30.95	278.66	7.36	29.2
Enterprise value over EBITDA	91.4	-91.78	132.51	11.82	58.02
EV to operating cash flow	16.72	-10.97	-10.32	137.87	-29.79
EV to free cash flow	16.72	-10.97	-10.32	137.87	-29.79
Earnings yield	0.03	-0.05	0.03	-0.06	0.02
Free cash flow yield	0.1	-0.2	-0.23	0.02	-0.08
Debt to equity	1	1.28	1.2	1.42	0
Debt to assets	0.5	0.56	0.54	0.59	0
Net debt to EBITDA	36.81	-49.02	77.2	6.9	32.79
Current ratio	0	0	0	5.72	0
Interest coverage	-0.59	-0.49	-0.44	9.91	1.83
Income quality	9.5	5.37	-194.69	-0.54	-4.29
Dividend Yield	0.02	0.03	0.03	0.04	0.03
Payout ratio	0.59	-0.51	1.26	-0.69	1.77
Sales general and administrative to revenue	0.2	0.06	0.53	0.02	0.04
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	13.49	14.12	9.35	13.23	7.57
ROIC	-0.01	0	-0.06	0.18	0.02
Return on tangible assets	0.02	-0.02	0.01	-0.02	0.01
Graham Net	-12.25	-15.29	-15.85	11.51	1.62
Working capital	51.28M	43.1M	6.86M	825.77M	57.29M
Tangible asset value	429.46M	404.32M	447.88M	419.94M	1.05B
Net current asset value	-379.85M	-474.64M	-528.87M	406.17M	57.29M
Invested capital	0.97	1.23	1.14	1.77	1.48
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0.04	-0.05	0.02	-0.05	0.02
Capex per share	0	0	0	0	0

TPVG Dividend History

TPVG Frequently Asked Questions

What is TriplePoint Venture Growth BDC Corp. stock symbol ?

TriplePoint Venture Growth BDC Corp. is a US stock , located in Menlo park of Ca and trading under the symbol TPVG

Is TriplePoint Venture Growth BDC Corp. buy or a sell ?

4 stock analysts have 4 predictions with a medium analyst target price of $15.75. The lowest prediction is $13.5 and the highest is $18

What is TPVG stock prediction ?

What is TriplePoint Venture Growth BDC Corp. stock quote today ?

TriplePoint Venture Growth BDC Corp. stock price is $11.73 today.

Is TriplePoint Venture Growth BDC Corp. stock public?

Yes, TriplePoint Venture Growth BDC Corp. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 305.04K
Market Capitalization 381.94M
CEO Mr. James P. Labe
Headquarters Menlo Park,CA,US
IPO Date 2014-03-06
Website https://www.tpvg.com

TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.